Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The Cosmetic Ingredients Review (CIR) Board has assigned an INCI name to Proteoderm's Matrix NC-138 cosmeceutical product.
Subscribe to our email newsletter
Proteoderm has used non-embryonic stem cells to develop a matrix of proteins (Matrix NC-138) used to harness the anti-aging potential in cosmeceutical products.
Proteonomix president Michael Cohen said the issuance of the INCI name will allow the company to move forward with commercialization of their NC-138 cosmeceutical product in the US.